Geron Corporation has appointed Chinmaya Rath as its new Chief Business Officer. Rath brings over 25 years of biopharma leadership experience, including a significant tenure at Novartis where he led enterprise-wide strategic initiatives such as the integrations of GSK Oncology and Alcon. Most recently, he served as Head of Pharma Solutions at Cellworks and Chief Business Officer at GlycoMimetics. Geron's President and CEO Harout Semerjian stated that Rath's appointment underscores the company's dedication to maximizing the value of RYTELO globally and building a leading hematology company. Rath highlighted RYTELO's best-in-class profile and strong commercial performance in lower-risk myelodysplastic syndromes as positioning Geron for continued growth.
Geron CorporationAppointment of experienced Chief Business Officer to maximize value of RYTELO and build leading hematology company.
Novartis AG